{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:53:13Z","timestamp":1648723993776},"reference-count":26,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1248\/bpb.b19-01065","type":"journal-article","created":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T22:08:14Z","timestamp":1588284494000},"page":"859-863","source":"Crossref","is-referenced-by-count":0,"title":["Abnormal Vascular Phenotypes Associated with the Timing of Interruption of Retinal Vascular Development in Rats"],"prefix":"10.1248","volume":"43","author":[{"given":"Ryo","family":"Kondo","sequence":"first","affiliation":[{"name":"Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayuki","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akane","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Organic Synthesis, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sakamoto","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Nagamitsu","sequence":"additional","affiliation":[{"name":"Department of Organic Synthesis, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Nakahara","sequence":"additional","affiliation":[{"name":"Department of Molecular Pharmacology, Kitasato University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Amadio M, Govoni S, Pascale A. Targeting VEGF in eye neovascularization: what\u2019s new?: a comprehensive review on current therapies and oligonucleotide-based interventions under development. <i>Pharmacol. Res.<\/i>, <b>103<\/b>, 253\u2013269 (2016)."},{"key":"2","unstructured":"2) Liu CH, Wang Z, Sun Y, Chen J. Animal models of ocular angiogenesis: from development to pathologies. <i>FASEB J.<\/i>, <b>31<\/b>, 4665\u20134681 (2017)."},{"key":"3","unstructured":"3) Ricci B, Calogero G. Oxygen-induced retinopathy in newborn rats: effects of prolonged normobaric and hyperbaric oxygen supplementation. <i>Pediatrics<\/i>, <b>82<\/b>, 193\u2013198 (1988)."},{"key":"4","unstructured":"4) Ventresca MR, Gonder JR, Tanswell AK. Oxygen-induced proliferative retinopathy in the newborn rat. <i>Can. J. Ophthalmol.<\/i>, <b>25<\/b>, 186\u2013189 (1990)."},{"key":"5","unstructured":"5) Penn JS, Tolman BL, Lowery LA. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>34<\/b>, 576\u2013585 (1993)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Penn JS, Henry MM, Tolman BL. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. <i>Pediatr. Res.<\/i>, <b>36<\/b>, 724\u2013731 (1994).","DOI":"10.1203\/00006450-199412000-00007"},{"key":"7","unstructured":"7) Smith LE, Wesolowski E, McLellan A, Kostyk SK, D\u2019Amato R, Sullivan R, D\u2019Amore PA. Oxygen-induced retinopathy in the mouse. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>35<\/b>, 101\u2013111 (1994)."},{"key":"8","unstructured":"8) Reynaud X, Dorey CK. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>35<\/b>, 3169\u20133177 (1994)."},{"key":"9","unstructured":"9) Zhang S, Leske DA, Holmes JM. Neovascularization grading methods in a rat model of retinopathy of prematurity. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>41<\/b>, 887\u2013891 (2000)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hartnett ME. The effects of oxygen stresses on the development of features of severe retinopathy of prematurity: knowledge from the 50\/10 OIR model. <i>Doc. Ophthalmol.<\/i>, <b>120<\/b>, 25\u201339 (2010).","DOI":"10.1007\/s10633-009-9181-x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Stahl A, Connor KM, Sapieha P, Chen J, Dennison RJ, Krah NM, Seaward MR, Willett KL, Aderman CM, Guerin KI, Hua J, L\u00f6fqvist C, Hellstr\u00f6m A, Smith LE. The mouse retina as an angiogenesis model. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>51<\/b>, 2813\u20132826 (2010).","DOI":"10.1167\/iovs.10-5176"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Ozaki H, Seo MS, Ozaki K, Yamada H, Yamada E, Okamoto N, Hofmann F, Wood JM, Campochiaro PA. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. <i>Am. J. Pathol.<\/i>, <b>156<\/b>, 697\u2013707 (2000).","DOI":"10.1016\/S0002-9440(10)64773-6"},{"key":"13","unstructured":"13) Gu X, Samuel S, El-Shabrawey M, Caldwell RB, Bartoli M, Marcus DM, Brooks SE. Effects of sustained hyperoxia on revascularization in experimental retinopathy of prematurity. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>43<\/b>, 496\u2013502 (2002)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Morita A, Nakahara T, Abe N, Kurauchi Y, Mori A, Sakamoto K, Nagamitsu T, Ishii K. Effects of pre- and post-natal treatment with KRN633, an inhibitor of vascular endothelial growth factor receptor tyrosine kinase, on retinal vascular development and patterning in mice. <i>Exp. Eye Res.<\/i>, <b>120<\/b>, 127\u2013137 (2014).","DOI":"10.1016\/j.exer.2014.01.009"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Nakano A, Nakahara T, Mori A, Ushikubo H, Sakamoto K, Ishii K. Short-term treatment with VEGF receptor inhibitors induces retinopathy of prematurity-like abnormal vascular growth in neonatal rats. <i>Exp. Eye Res.<\/i>, <b>143<\/b>, 120\u2013131 (2016).","DOI":"10.1016\/j.exer.2015.10.016"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nakano A, Asano D, Kondo R, Mori A, Arima S, Ushikubo H, Sakamoto K, Nagamitsu T, Ishii K, Nakahara T. Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity. <i>Exp. Eye Res.<\/i>, <b>168<\/b>, 115\u2013127 (2018).","DOI":"10.1016\/j.exer.2017.12.007"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Morita A, Mori A, Arima S, Sakamoto K, Nagamitsu T, Ishii K, Nakahara T. Transient phenotypic changes in endothelial cells and pericytes in neonatal mouse retina following short-term blockade of vascular endothelial growth factor receptors. <i>Dev. Dyn.<\/i>, <b>247<\/b>, 699\u2013711 (2018).","DOI":"10.1002\/dvdy.24614"},{"key":"18","unstructured":"18) Nakamura K, Yamamoto A, Kamishohara M, Takahashi K, Taguchi E, Miura T, Kubo K, Shibuya M, Isoe T. KRN633: a selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth. <i>Mol. Cancer Ther.<\/i>, <b>3<\/b>, 1639\u20131649 (2004)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Stone J, Itin A, Alon T, Pe\u2019er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. <i>J. Neurosci.<\/i>, <b>15<\/b>, 4738\u20134747 (1995).","DOI":"10.1523\/JNEUROSCI.15-07-04738.1995"},{"key":"20","unstructured":"20) Hartnett ME, Martiniuk D, Byfield G, Geisen P, Zeng G, Bautch VL. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>49<\/b>, 3107\u20133114 (2008)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Lutty GA, McLeod DS, Bhutto I, Wiegand SJ. Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>52<\/b>, 4039\u20134047 (2011).","DOI":"10.1167\/iovs.10-6798"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Zhang W, Yokota H, Xu Z, Narayanan SP, Yancey L, Yoshida A, Marcus DM, Caldwell RW, Caldwell RB, Brooks SE. Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>52<\/b>, 6384\u20136395 (2011).","DOI":"10.1167\/iovs.11-7666"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Rabinowitz R, Priel A, Rosner M, Pri-Chen S, Spierer A. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity. <i>Curr. Eye Res.<\/i>, <b>37<\/b>, 624\u2013629 (2012).","DOI":"10.3109\/02713683.2012.669003"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Guaiquil VH, Hewing NJ, Chiang MF, Rosenblatt MI, Chan RV, Blobel CP. A murine model for retinopathy of prematurity identifies endothelial cell proliferation as a potential mechanism for plus disease. <i>Invest. Ophthalmol. Vis. Sci.<\/i>, <b>54<\/b>, 5294\u20135302 (2013).","DOI":"10.1167\/iovs.12-11492"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, Hu-Lowe D, McDonald DM. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>290<\/b>, H547\u2013H559 (2006).","DOI":"10.1152\/ajpheart.00616.2005"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O\u2019Brien SM, Davis RB, Gowen LC, Anderson KD, Thurston G, Joho S, Springer ML, Kuo CJ, McDonald DM. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. <i>Am. J. Physiol. Heart Circ. Physiol.<\/i>, <b>290<\/b>, H560\u2013H576 (2006).","DOI":"10.1152\/ajpheart.00133.2005"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01065\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T06:34:01Z","timestamp":1588833241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/5\/43_b19-01065\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-01065","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}